Get the Stockscreener App
1.50
5.35%
-0.09
Humacyte Inc stock is traded at $1.50, with a volume of 3.18M.
It is down -5.35% in the last 24 hours and down -28.33% over the past month.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
See More
Previous Close:
$1.59
Open:
$1.55
24h Volume:
3.18M
Relative Volume:
0.60
Market Cap:
$239.05M
Revenue:
-
Net Income/Loss:
$-110.78M
P/E Ratio:
-1.4019
EPS:
-1.07
Net Cash Flow:
$-75.59M
1W Performance:
-11.47%
1M Performance:
-28.33%
6M Performance:
+14.89%
1Y Performance:
-70.32%
1-Day Range:
$1.48
$1.5584
1-Week Range:
$1.48
$1.78
52-Week Range:
$1.15
$6.77
Humacyte Inc Stock (HUMA) Company Profile
Name
Humacyte Inc
Sector
Industry
Phone
919-313-9633
Address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Compare HUMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
1.505 | 297.76M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.81 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.17 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.20 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.33 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.86 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-25 | Initiated | Barclays | Overweight |
| May-14-25 | Resumed | H.C. Wainwright | Buy |
| Dec-20-24 | Reiterated | H.C. Wainwright | Buy |
| Dec-11-23 | Initiated | H.C. Wainwright | Buy |
| Aug-14-23 | Upgrade | Piper Sandler | Underweight → Neutral |
| Jun-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-16-22 | Downgrade | Piper Sandler | Overweight → Underweight |
| Oct-29-21 | Initiated | Cowen | Outperform |
| Sep-24-21 | Initiated | Oppenheimer | Outperform |
| Sep-22-21 | Initiated | BTIG Research | Buy |
| Sep-16-21 | Initiated | Piper Sandler | Overweight |
View All
Humacyte Inc Stock (HUMA) Latest News
Will Humacyte Inc. see short term momentumEarnings Overview Summary & AI Driven Price Predictions - newser.com
Using data models to predict Humacyte Inc. Equity Warrant stock movementJuly 2025 Drop Watch & Smart Allocation Stock Reports - newser.com
Is Humacyte Inc. Equity Warrant stock vulnerable to regulatory risksShare Buyback & Step-by-Step Trade Execution Guides - newser.com
Quantitative breakdown of Humacyte Inc. recent moveMarket Activity Recap & Weekly Momentum Picks - newser.com
Will Humacyte Inc. stock attract more institutional investorsMarket Performance Recap & High Accuracy Swing Entry Alerts - newser.com
Market reaction to Humacyte Inc.’s recent newsEarnings Growth Report & High Accuracy Swing Trade Signals - newser.com
Is Humacyte Inc. Equity Warrant stock ready for a breakout2025 Buyback Activity & Risk Controlled Stock Alerts - newser.com
Is Humacyte Inc. stock supported by strong cash flowsPortfolio Risk Summary & Accurate Buy Signal Alerts - newser.com
Real time pattern detection on Humacyte Inc. stockWeekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Can Humacyte Inc. stock reach $100 price targetEarnings Beat & Weekly High Conviction Trade Ideas - newser.com
Will Humacyte Inc. Equity Warrant stock see insider buyingMarket Risk Report & Real-Time Volume Trigger Notifications - newser.com
How to interpret RSI for Humacyte Inc. stock2025 Price Targets & Precise Trade Entry Recommendations - newser.com
Can Humacyte Inc. Equity Warrant stock deliver consistent earnings growthDividend Hike & Weekly Breakout Watchlists - newser.com
Will Humacyte Inc. stock deliver shareholder value2025 Price Action Summary & Fast Entry Momentum Alerts - newser.com
Is Humacyte Inc. Equity Warrant stock attractive for growth ETFs2025 Biggest Moves & Step-by-Step Swing Trade Plans - newser.com
Why Humacyte Inc. Equity Warrant stock could outperform in 2025July 2025 News Drivers & Reliable Breakout Stock Forecasts - newser.com
Published on: 2025-11-03 03:47:12 - newser.com
Why Humacyte Inc. stock remains on buy listsJuly 2025 Spike Watch & Reliable Price Breakout Alerts - newser.com
Volume spikes in Humacyte Inc. Equity Warrant stock – what they meanCEO Change & High Return Trade Opportunity Guides - newser.com
Key metrics from Humacyte Inc.’s quarterly dataLayoff News & Smart Swing Trading Techniques - newser.com
Tick level data insight on Humacyte Inc. volatilityTrade Analysis Summary & Real-Time Price Movement Reports - newser.com
Why Is Bioengineered Human Tissue-Focused Humacyte Stock Surging On Friday? - AOL.com
Is Humacyte Inc. stock trading near support levels2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com
What recovery options are there for Humacyte Inc. Equity WarrantQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
Technical analysis overview for Humacyte Inc. Equity Warrant stockCPI Data & Advanced Technical Analysis Signals - newser.com
How Humacyte Inc. Equity Warrant stock performs in high volatility marketsEarnings Recap Report & Weekly High Conviction Ideas - newser.com
Is now a turning point for Humacyte Inc. Equity WarrantWeekly Trend Summary & Real-Time Buy Zone Alerts - newser.com
Predicting Humacyte Inc. trend using moving averages2025 Investor Takeaways & Daily Technical Stock Forecast Reports - newser.com
Multi asset correlation models including Humacyte Inc. Equity Warrant2025 Fundamental Recap & Community Driven Trade Alerts - newser.com
Should I hold or sell Humacyte Inc. Equity Warrant stock in 2025Earnings Summary Report & Free AI Powered Buy and Sell Recommendations - newser.com
Chart overlay techniques for tracking Humacyte Inc.July 2025 Snapshot & Community Verified Trade Alerts - newser.com
Will Humacyte Inc. stock benefit from infrastructure spendingWeekly Trading Summary & Risk Managed Investment Strategies - newser.com
Is Humacyte Inc. Equity Warrant stock a dividend growth opportunityJuly 2025 Levels & Reliable Entry Point Alerts - newser.com
Earnings visualization tools for Humacyte Inc.July 2025 PreEarnings & Long-Term Capital Growth Strategies - newser.com
Humacyte rises on Symvess sale to military treatment facility - MSN
Humacyte Inc Stock (HUMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):